Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ozurdex in Treatment of Macular Edema Post Membrane Peeling

NCT01273727 is registered in ClinicalTrials.gov with Retina Specialists, PC as lead sponsor.

NCT NCT01273727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01273727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ozurdex in Treatment of Macular Edema Post Membrane Peeling
Lead sponsor
Retina Specialists, PC
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2014
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cellophane maculopathy, epiretinal membrane, macular edema, retinal edema